Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-066634
Filing Date
2005-03-31
Accepted
2005-03-31 12:50:50
Documents
14
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1241533
2 RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT dex31.htm EX-3.1 47356
3 AMENDED AND RESTATED BYLAWS OF THE REGISTRANT dex32.htm EX-3.2 101982
4 2004 STOCK INCENTIVE PLAN dex102.htm EX-10.2 60872
5 FORM OF INCENTIVE STOCK OPTION AGREEMENT dex103.htm EX-10.3 24326
6 FORM OF NONSTATUTORY STOCK OPTION AGREEMENT dex104.htm EX-10.4 23743
7 SUMMARY OF DIRECTOR COMPENSATION dex105.htm EX-10.5 2819
8 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1913
9 CERTIFICATION OF CEO dex311.htm EX-31.1 9707
10 CERTIFICATION OF CFO dex312.htm EX-31.2 10407
11 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3516
12 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3502
14 GRAPHIC g27714g38s29.jpg GRAPHIC 67875
15 GRAPHIC g27714g93r51.jpg GRAPHIC 56487
  Complete submission text file 0001193125-05-066634.txt   1659172
Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Filer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50676 | Film No.: 05718128
SIC: 2834 Pharmaceutical Preparations